India’s drug manufacturing is booming under supportive policies. The pharmaceutical CDMO (contract development & manufacturing) market is projected to nearly triple by 2029. India can provide pharma production ~20% cheaper than Chinese competitors, and its vaccine/manufacturing infrastructure (e.g. for COVID vaccines) underscores its global role.
Jade SEA Consultancy 